-
1994,
Parris WCV, Janicki PK
Analgesia 1: 57-64
-
Bioelectromagnetics 14 (6): 553-556
-
1993,
Kavaliers M, Ossenkopp KP
Brain Res 620 (1): 159-162
-
1992,
Maillefer RH, Quock RM
Physiol Behav 52 (3): 511-514
-
1992,
Foley-Nolan D, Moore K, Codd M, Barry C, O'Connor P, Coughlan RJ
Scand J Rehabil Med 24 (1): 51-59
-
1992,
Prato FS, Kavaliers M, Ossenkopp KP, Carson JJ, Drost DJ, Frappier JR
Ann N Y Acad Sci 649: 44-58
-
1991,
Tysdale DM, Lipa SM, Ossenkopp KP, Kavaliers M
Physiol Behav 49 (1): 53-56
-
1991,
Kavaliers M, Ossenkopp KP, Tysdale DM
Brain Res 554 (1-2): 65-71
-
J Bioelectricity 9 (2): 187-196
-
1990,
Kavaliers M, Ossenkopp KP, Lipa SM
Brain Res 517 (1-2): 276-282
-
1988,
Kavaliers M, Ossenkopp KP
J Comp Physiol A 162 (4): 551-558
-
1988,
Ossenkopp KP, Kavaliers M
J Bioelectricity 7 (2): 189-208
-
1988,
Kavaliers M, Ossenkopp KP
Pain 32 (2): 223-229
-
1988,
Teskey GC, Prato FS, Ossenkopp KP, Kavaliers M
Bioelectromagnetics 9 (2): 167-174
-
1987,
Kavaliers M, Ossenkopp KP
Prog Neuropsychopharmacol Biol Psychiatry 11 (2-3): 279-286
-
1987,
Kavaliers M, Ossenkopp KP
Naunyn Schmiedebergs Arch Pharmacol 336 (3): 308-315
-
1987,
Kavaliers M, Innes DG
Physiol Behav 40 (5): 559-562
-
1987,
Prato FS, Ossenkopp KP, Kavaliers M, Sestini E, Teskey GC
Magn Reson Imaging 5 (1): 9-14
-
1987,
Ossenkopp KP, Kavaliers M
Brain Res 418 (2): 356-360
-
1986,
Kavaliers M, Ossenkopp KP
Psychopharmacology 89 (4): 440-443
-
1986,
Kavaliers M, Ossenkopp KP
Brain Res 379 (1): 30-38
-
1986,
Kavaliers M, Ossenkopp KP
Peptides 7 (3): 449-453
-
1985,
Jacchia GE, Calabrese C, Innocenti M
Bioelectrochem Bioenerg 14 (1-3): 169-174
-
1985,
Kavaliers M, Ossenkopp KP
Prog Neuropsychopharmacol Biol Psychiatry 9 (5-6): 713-716
-
1985,
Kavaliers M, Ossenkopp KP
Neuropharmacology 24 (4): 337-340